Income Statement
ADAGIO MEDICAL HOLDINGS, INC.
ADGM
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY |
|---|---|---|
|
Revenue
|
0.00 | - |
|
Cost of Revenue
|
0.68 | - |
|
Gross Profit
|
-0.68 | - |
|
Operating Expenses
|
21.21 | 0.00 |
|
Research & Development
|
10.64 | - |
|
Selling, General & Administrative
|
10.57 | - |
|
Other Operating Expenses
|
- | - |
|
Operating Income
|
-21.89 | - |
|
Non-Operating Income
|
-3.19 | - |
|
Interest Income
|
0.48 | - |
|
Interest Expense
|
2.90 | - |
|
Other Non-Op Income / Expense
|
0.20 | - |
|
Income Before Tax
|
-25.32 | - |
|
Income Tax Expense
|
- | - |
|
Non-Controlling Interest
|
- | - |
|
Net Income
|
-25.08 | - |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY |
|---|---|---|
|
Depreciation & Amortization
|
- | - |
|
EBITDA
|
-20.92 | 0.00 |
|
Earnings Per Share (Basic)
|
-1.51 | - |
|
Diluted EPS
|
-1.51 | - |
|
Weighted Average Shares
|
16.58 | - |
|
Diluted Weighted Avg Shares
|
16.58 | - |
|
Comprehensive Income
|
-25.18 | - |